Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03871387Completed
Randomised trial of rocuronium in thyroid neoplasms (2 arms), sponsored by Yonsei University. Primary endpoint: Postoperative pain: Numerical Rating Scale at 3 days. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03871387.